<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T00:45:32Z</responseDate>
  <request identifier="oai:figshare.com:article/34037145" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34037145</identifier>
        <datestamp>2026-09-30T23:04:11Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Rare-Earth-Coordinated
Glutamine Nanostructure-Induced
“Pseudo-Overnutrition” Metabolic Therapy</dc:title>
          <dc:creator>Junrong Wang (28268)</dc:creator>
          <dc:creator>Mengqian Xu (16324682)</dc:creator>
          <dc:creator>Guoqing Zhu (10898589)</dc:creator>
          <dc:creator>Shanshan Zhang (50616)</dc:creator>
          <dc:creator>Yunlong Li (117641)</dc:creator>
          <dc:creator>Ping’an Ma (1524742)</dc:creator>
          <dc:creator>Jun Lin (509093)</dc:creator>
          <dc:creator>Chunxia Li (182841)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>termed “ pseudo</dc:subject>
          <dc:subject>subsequently internalized predominantly</dc:subject>
          <dc:subject>induced “ pseudo</dc:subject>
          <dc:subject>even promote invasion</dc:subject>
          <dc:subject>enhancing antigen presentation</dc:subject>
          <dc:subject>blocks mtorc1 activation</dc:subject>
          <dc:subject>activating antitumor immunity</dc:subject>
          <dc:subject>gln preferentially interacts</dc:subject>
          <dc:subject>gln disrupts v</dc:subject>
          <dc:subject>triggering metabolic collapse</dc:subject>
          <dc:subject>rendering cells unable</dc:subject>
          <dc:subject>glutamine microenvironment induced</dc:subject>
          <dc:subject>coordinated glutamine nanostructure</dc:subject>
          <dc:subject>previously unrecognized concept</dc:subject>
          <dc:subject>metabolic therapeutic strategy</dc:subject>
          <dc:subject>accumulates within lysosomes</dc:subject>
          <dc:subject>gln ).</dc:subject>
          <dc:subject>therapeutic vulnerability</dc:subject>
          <dc:subject>metabolic plasticity</dc:subject>
          <dc:subject>metabolic intervention</dc:subject>
          <dc:subject>dendritic cells</dc:subject>
          <dc:subject>glutamine transporters</dc:subject>
          <dc:subject>yet nutrient</dc:subject>
          <dc:subject>strong dependency</dc:subject>
          <dc:subject>resulting dysfunction</dc:subject>
          <dc:subject>progressive accumulation</dc:subject>
          <dc:subject>overnutrition ”.</dc:subject>
          <dc:subject>overnutrition ”</dc:subject>
          <dc:subject>nutrient utilization</dc:subject>
          <dc:subject>mechanistic framework</dc:subject>
          <dc:subject>leverages rather</dc:subject>
          <dc:subject>glucose metabolism</dc:subject>
          <dc:subject>effectively utilized</dc:subject>
          <dc:subject>confined primarily</dc:subject>
          <dc:subject>compensatory mechanisms</dc:subject>
          <dc:subject>cell membranes</dc:subject>
          <dc:description>Tumor cells display a strong dependency on nutrients,
yet nutrient-deprivation
strategies often fail due to their metabolic plasticity and compensatory
mechanisms, and can even promote invasion and metastasis. Here, we
propose a metabolic therapeutic strategy that leverages rather than
suppresses tumor nutrient addiction, termed “pseudo-overnutrition”.
This approach induces tumor cells to continuously uptake nutrient
analogs that cannot be effectively utilized, thereby decoupling nutrient
input from nutrient utilization and triggering metabolic collapse.
To validate this concept, we designed and assembled rare-earth–coordinated
glutamine nanoparticles (RE-Gln). RE-Gln preferentially interacts
with glutamine transporters on tumor-cell membranes, is subsequently
internalized predominantly through macropinocytosis, and accumulates
within lysosomes. The progressive accumulation of RE-Gln disrupts
V-ATPase–dependent lysosomal nutrient sensing and blocks mTORC1
activation, rendering cells unable to effectively utilize nutrients
despite continuous uptake. Importantly, the resulting dysfunction
is confined primarily to lysosomes, while mitochondrial integrity
remains preserved. This lysosome-centered impairment ultimately causes
widespread disruption of glutamine and glucose metabolism. Moreover,
the high-glutamine microenvironment induced by RE-Gln impairs lysosomal
biogenesis and function in dendritic cells, enhancing antigen presentation
and activating antitumor immunity. These findings establish “pseudo-overnutrition”
as a previously unrecognized concept for metabolic intervention in
cancer and provide a mechanistic framework for converting tumor nutrient
dependency into a therapeutic vulnerability.</dc:description>
          <dc:date>2026-09-30T00:00:00Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.1021/jacs.6c13842.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/Rare-Earth-Coordinated_Glutamine_Nanostructure-Induced_Pseudo-Overnutrition_Metabolic_Therapy/34037145</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
